Tiffany Coughenour
Physician Assistant · Idaho Falls, IDNPI 1205959756
Payments from drug & device makers
Across 277 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$571
- Boehringer Ingelheim$215
- Novo Nordisk$177
- Lilly USA, LLC$156
- GSK$112
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,232100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 139 | $1,781 |
| AbbVie | 27 | $571 |
| Boehringer Ingelheim | 13 | $215 |
| Novo Nordisk | 12 | $177 |
| Lilly USA, LLC | 12 | $156 |
| GSK | 7 | $112 |
| Medtronic | 7 | $109 |
| Dexcom, Inc. | 5 | $104 |
| Novartis | 5 | $89 |
| Insulet Corporation | 4 | $89 |
| Astellas Pharma US Inc | 3 | $83 |
| Johnson & Johnson | 5 | $82 |
| Abbott | 4 | $73 |
| Edwards Lifesciences | 2 | $59 |
| Tandem Diabetes Care, Inc. | 2 | $58 |
| Mylan Specialty L.p. | 3 | $57 |
| Pfizer | 3 | $46 |
| AstraZeneca | 3 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Boston Scientific | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Kerecis Limited | 2 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Corcept Therapeutics | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$4,232 in reported general payments places this provider in the 90th percentile of 1,027 physician assistant providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 94 | $123,892 |
| MounjaroTirzepatide | 100 | $110,543 |
| EliquisApixaban | 76 | $78,928 |
| JardianceEmpagliflozin | 45 | $42,444 |
| FarxigaDapagliflozin Propanediol | 24 | $29,589 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $29,505 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $23,833 |
| TrulicityDulaglutide | 20 | $19,242 |
| MyrbetriqMirabegron | 14 | $12,333 |
| JanuviaSitagliptin Phosphate | 14 | $9,833 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $9,249 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $6,216 |
| Levothyroxine Sodium | 329 | $3,704 |
| Omeprazole | 295 | $3,456 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $3,361 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $156 | $129,785120 claims |
| Novo NordiskOzempic | $177 | $123,89294 claims |
| PfizerEliquis | $46 | $78,92876 claims |
| Boehringer IngelheimJardiance | $215 | $42,44445 claims |
| AstraZenecaFarxiga | $42 | $29,58924 claims |
| Astellas Pharma US IncMyrbetriq | $83 | $12,33314 claims |
| GSKAnoro Ellipta | $112 | $6,21611 claims |
| AbbVieSynthroid | $571 | $1,29137 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Idaho Falls
- Tyler PondIdaho Falls$13K
- Jed WillardsonIdaho Falls$12K
- Joshua KillpackIdaho Falls$11K
- Phillip MarloweIdaho Falls$10K
- Tyson ParkerIdaho Falls$10K
- Rebecca NewbyIdaho Falls$9K
- Todd CranorIdaho Falls$9K
- Lindsi GordonIdaho Falls$9K
- Amanda ColemanIdaho Falls$7K
- Alan AdamsIdaho Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.